New triple therapy aims to control liver-metastatic colorectal cancer in late-stage patients
NCT ID NCT07353268
First seen Jan 31, 2026 · Last updated May 12, 2026 · Updated 8 times
Summary
This study tests whether a new combination of an antibody drug (QL1706), a targeted therapy (fruquintinib), and short-course radiotherapy can help control advanced colorectal cancer that has spread to the liver and hasn't responded to earlier treatments. About 76 adults aged 18 to 75 with a specific type of colorectal cancer (pMMR/MSS) will be enrolled. The goal is to see if this approach is safer and more effective than standard third-line therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.